Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14
Wolmark, N., Mamounas, E. P., Baehner, F. L., Butler, S. M., Tang, G., Jamshidian, F., Sing, A. P., Shak, S., Paik, S.Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2015.62.6630
Date:
May, 2016
File:
PDF, 1.29 MB
english, 2016